EA Pharma Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Tokyo Japan (2016)

Organization Overview

First Clinical Trial
2016
NCT02063854
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

EA Pharma Co., Ltd.